RF

Ryohei Fukuyama

Active Director Director DIN 10534517
DIN 10534517 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ryohei Fukuyama

Data last updated:

Ryohei Fukuyama is a Director at Otsuka Nutraceutical India Private Limited (since 2024). The company operates in Healthcare.

DIN 10534517
Primary Designation Director
Industry Healthcare
First Appointment 04 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Mar 20242024Active

Board colleagues of Ryohei Fukuyama

Directorship timeline

Open interactive timeline →
Otsuka Nutraceutical India Private Limited
Premium access

Shareholding and investment profile for Ryohei Fukuyama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ryohei Fukuyama

Ryohei Fukuyama currently holds 1 directorship: Otsuka Nutraceutical India Private Limited (Director, since 04 Mar 2024).

Ryohei Fukuyama was first appointed on 04 Mar 2024 as Director at Otsuka Nutraceutical India Private Limited.

The current boards of Ryohei Fukuyama's companies include Kinjal Harilal Patel (Otsuka Nutraceutical India Private Limited), Parag Avinashbhai Swadia (Otsuka Nutraceutical India Private Limited), Takuhiro Tanaka (Otsuka Nutraceutical India Private Limited), Yoshihiro Bando (Otsuka Nutraceutical India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available